Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon M Kelly

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Substance Abuse|July 8, 2017
The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health centerSharon M Kelly, Kevin E O'Grady, Jan Gryczynski, et al.
Biochimica Et Biophysica Acta|May 24, 2006
Circular dichroism studies of subtilisin Carlsberg immobilised on micron sized silica particlesAshok Ganesan, Nicholas C Price, Sharon M Kelly, et al.
Pediatrics|April 23, 2014
Validity of brief screening instrument for adolescent tobacco, alcohol, and drug useSharon M Kelly, Jan Gryczynski, Shannon Gwin Mitchell, et al.
Addiction (Abingdon, England)|October 15, 2014
Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patientsJan Gryczynski, Sharon M Kelly, Shannon Gwin Mitchell, et al.
Journal of Substance Abuse Treatment|December 23, 2018
Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrestsRobert P Schwartz, Sharon M Kelly, Shannon Gwin Mitchell, et al.
Journal of Substance Abuse Treatment|November 19, 2013
Interim versus standard methadone treatment: a benefit-cost analysisRobert P Schwartz, Pierre K Alexandre, Sharon M Kelly, et al.
Substance Abuse|January 24, 2012
Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crimeJan Gryczynski, Timothy W Kinlock, Sharon M Kelly, et al.
Organic & Biomolecular Chemistry|September 30, 2004
Sensing of remote oxyanion binding at the DNA binding domain of the molybdate-dependent transcriptional regulator, ModEDavid H Boxer, Han Zhang, David G Gourley, et al.
European Journal of Biochemistry|May 3, 2002
The refolding of type II shikimate kinase from Erwinia chrysanthemi after denaturation in ureaEleonora Cerasoli, Sharon M Kelly, John R Coggins, et al.
Drug and Alcohol Dependence|September 30, 2017
When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest recordsRobert P Schwartz, Sharon M Kelly, Shannon Gwinn Mitchell, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Substance Abuse|July 8, 2017
The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health centerSharon M Kelly, Kevin E O'Grady, Jan Gryczynski, et al.
Biochimica Et Biophysica Acta|May 24, 2006
Circular dichroism studies of subtilisin Carlsberg immobilised on micron sized silica particlesAshok Ganesan, Nicholas C Price, Sharon M Kelly, et al.
Pediatrics|April 23, 2014
Validity of brief screening instrument for adolescent tobacco, alcohol, and drug useSharon M Kelly, Jan Gryczynski, Shannon Gwin Mitchell, et al.
Addiction (Abingdon, England)|October 15, 2014
Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patientsJan Gryczynski, Sharon M Kelly, Shannon Gwin Mitchell, et al.
Journal of Substance Abuse Treatment|December 23, 2018
Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrestsRobert P Schwartz, Sharon M Kelly, Shannon Gwin Mitchell, et al.
Journal of Substance Abuse Treatment|November 19, 2013
Interim versus standard methadone treatment: a benefit-cost analysisRobert P Schwartz, Pierre K Alexandre, Sharon M Kelly, et al.
Substance Abuse|January 24, 2012
Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crimeJan Gryczynski, Timothy W Kinlock, Sharon M Kelly, et al.
Organic & Biomolecular Chemistry|September 30, 2004
Sensing of remote oxyanion binding at the DNA binding domain of the molybdate-dependent transcriptional regulator, ModEDavid H Boxer, Han Zhang, David G Gourley, et al.
European Journal of Biochemistry|May 3, 2002
The refolding of type II shikimate kinase from Erwinia chrysanthemi after denaturation in ureaEleonora Cerasoli, Sharon M Kelly, John R Coggins, et al.
Drug and Alcohol Dependence|September 30, 2017
When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest recordsRobert P Schwartz, Sharon M Kelly, Shannon Gwinn Mitchell, et al.
Pageof 14